Disclaimer:

Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.

TetraVisc

×

Overview

What is TetraVisc?



What does TetraVisc look like?



What are the available doses of TetraVisc?

Sorry No records found.

What should I talk to my health care provider before I take TetraVisc?

Sorry No records found

How should I use TetraVisc?

For procedures in which a rapid and short acting topical ophthalmic anesthetic is indicated such as in tonometry, gonioscopy,removal of corneal foreign bodies, conjunctival scraping for diagnostic purposes, suture removal from the cornea or conjunctiva,other short corneal and conjunctival procedures.

One to two drops per eye.For Tonometry And Other Procedures Of Short Duration:Instill one or two drops just prior to evaluation.For Minor Surgical Procedures Such As Foreign Body Or Suture Removal:Instill one or two drops in the eye(s) every five to ten minutes maximum three doses.For Prolonged Anesthesia As In Cataract Extraction:Instill one or two drops in the eye(s) every five to ten minutes maximum five doses.


What interacts with TetraVisc?

Sorry No Records found


What are the warnings of TetraVisc?

Sorry No Records found


What are the precautions of TetraVisc?

Sorry No Records found


What are the side effects of TetraVisc?

Transient symptoms (signs) such as stinging, burning, and conjunctival redness may occur. A rare, severe, immediate typeallergic corneal reaction has been reported characterized by acute diffuse epithelial keratitis with filament formation and/orsloughing of large areas of necrotic epithelium, diffuse stromal edema, descemetitis and iritis.

To report SUSPECTED ADVERSE REACTIONS, contact OCuSOFT, Inc. at (800) 233-5469 www.ocusoft.com.


What should I look out for while using TetraVisc?

Should not be used by the patient without physician supervision, or in those persons showing hypersensitivity to any componentof this preparation.

For topical ophthalmic use only. Not for parenteral use. Not for injection. Do not use solution if it contains crystals or if it is cloudyor discolored. Prolonged use results in diminished duration of anesthesia and retarded healing. This may cause the drug to beused more frequently, creating a "vicious circle". Subsequent corneal infection and/or corneal opacification with accompanyingpermanent visual loss or corneal perforation may occur. Prolonged use may also produce severe keratitis.


What might happen if I take too much TetraVisc?

Sorry No Records found


How should I store and handle TetraVisc?

Store at 20-25°C (68-77°F). Excursions permitted to 15-30°C (59-86°F). [See USP Controlled Room Temperature.] Protect from light.Dispense in a tight, light-resistant container with a child-resistant closure.Store at 20-25°C (68-77°F). Excursions permitted to 15-30°C (59-86°F). [See USP Controlled Room Temperature.] Protect from light.Dispense in a tight, light-resistant container with a child-resistant closure.Tetracaine Hydrochloride Ophthalmic Solution , USP 0.5% is supplied in:5 mL multi-drop plastic container NDC 54799-505-050.6 mL single unit dose plastic container NDC 54799-505-01


×

Clinical Information

Chemical Structure

No Image found
Clinical Pharmacology

Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5% acts by decreasing the permeability of the neuronal membrane,thereby decreasing the flux of sodium, potassium and other ions associated with propagation of the nerve impulse. The onsetof anesthesia usually begins within 30 seconds and lasts a relatively short period of time.

Non-Clinical Toxicology
Should not be used by the patient without physician supervision, or in those persons showing hypersensitivity to any componentof this preparation.

For topical ophthalmic use only. Not for parenteral use. Not for injection. Do not use solution if it contains crystals or if it is cloudyor discolored. Prolonged use results in diminished duration of anesthesia and retarded healing. This may cause the drug to beused more frequently, creating a "vicious circle". Subsequent corneal infection and/or corneal opacification with accompanyingpermanent visual loss or corneal perforation may occur. Prolonged use may also produce severe keratitis.

In common with other antibiotics, cefuroxime may affect the gut flora, leading to lower estrogen reabsorption and reduce efficacy of combined estrogen/progesterone oral contraceptives.

Do not touch dropper tip to any surface as this may contaminate the solution. As with all anesthetics, continuous and prolongeduse should be avoided. Protection of the eye from irritating chemicals, foreign bodies and rubbing during the period ofanesthesia is very important. Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5% should be used cautiously in patientswith known allergy or cardiac disease. If signs of sensitivity develop during the treatment or irritation persists or increases,patients should be advised to discontinue use and consult prescribing physician.

Transient symptoms (signs) such as stinging, burning, and conjunctival redness may occur. A rare, severe, immediate typeallergic corneal reaction has been reported characterized by acute diffuse epithelial keratitis with filament formation and/orsloughing of large areas of necrotic epithelium, diffuse stromal edema, descemetitis and iritis.

To report SUSPECTED ADVERSE REACTIONS, contact OCuSOFT, Inc. at (800) 233-5469 www.ocusoft.com.

×

Reference

This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"

While we update our database periodically, we cannot guarantee it is always updated to the latest version.

×

Review

Rate this treatment and share your opinion


Learn about User Reviews

Helpful tips to write a good review:

  1. Only share your first hand experience as a consumer or a care giver.
  2. Describe your experience in the Comments area including the benefits, side effects and how it has worked for you. Do not provide personal information like email addresses or telephone numbers.
  3. Fill in the optional information to help other users benefit from your review.

Reason for Taking This Treatment

(required)

Click the stars to rate this treatment

Effectiveness (required)

This medication has worked for me.




Ease of Use (required)

This medication has been easy for me to use.




Satisfaction (required)

Overall, I have been satisfied with my experience.




Write a brief description of your experience with this treatment:

2000 characters remaining

Optional Information

Help others benefit from your review by filling in the information below.
I am a:
Gender:
×

Professional

Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72
×

Tips

Tips

×

Interactions

Interactions

A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).